PCR-mediated recombination: a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA.

scientific article published in February 1999

PCR-mediated recombination: a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1009300190
P356DOI10.1038/5607
P698PubMed publication ID9930876

P2093author name stringFang G
Burger H
Moran T
Weiser B
Visosky A
P2860cites workHigh-fidelity amplification using a thermostable DNA polymerase isolated from Pyrococcus furiosusQ50799142
PCR-mediated recombination and mutagenesis. SOEing together tailor-made genesQ71914926
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCRQ22242246
DNA polymerase fidelity and the polymerase chain reactionQ28277408
Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extensionQ29547330
HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapyQ29616404
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionQ29619738
Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction.Q30416612
Full length mouse glycophorin gene constructed using recombinant polymerase chain reactionQ33568392
Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmissionQ33647718
A rapid PCR fidelity assayQ40411280
Creating chimeric molecules by PCR directed homologous DNA recombinationQ40504068
Fidelity of DNA synthesis by the Thermococcus litoralis DNA polymerase--an extremely heat stable enzyme with proofreading activityQ40507004
DNA recombination during PCR.Q40515497
Constructing DNA by polymerase recombinationQ40518077
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)239-242
P577publication date1999-02-01
P1433published inNature MedicineQ1633234
P1476titlePCR-mediated recombination: a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA.
P478volume5

Reverse relations

cites work (P2860)
Q40316516A new hybrid bacteriocin, Ent35-MccV, displays antimicrobial activity against pathogenic Gram-positive and Gram-negative bacteria
Q42379498A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency.
Q37511426Accurate representation of the hepatitis C virus quasispecies in 5.2-kilobase amplicons
Q37583389Amino acid insertions near Gag cleavage sites restore the otherwise compromised replication of human immunodeficiency virus type 1 variants resistant to protease inhibitors
Q36736848C-5-Modified Tetrahydropyrano-Tetrahydofuran-Derived Protease Inhibitors (PIs) Exert Potent Inhibition of the Replication of HIV-1 Variants Highly Resistant to Various PIs, including Darunavir
Q36015423CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable
Q40251352Early phase dynamics of traceable mCherry fluorescent protein-carrying HIV-1 infection in human peripheral blood mononuclear cells-transplanted NOD/SCID/Jak3-/- mice
Q35914553Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees
Q45731952Inclusion of full length human immunodeficiency virus type 1 (HIV-1) gag sequences in viral recombinants applied to drug susceptibility phenotyping
Q46950457Intron-mediated alternative splicing of WOOD-ASSOCIATED NAC TRANSCRIPTION FACTOR1B regulates cell wall thickening during fiber development in Populus species
Q41419244Ligand binding modes from low resolution GPCR models and mutagenesis: chicken bitter taste receptor as a test-case.
Q35382383Loss of protease dimerization inhibition activity of darunavir is associated with the acquisition of resistance to darunavir by HIV-1.
Q36414526Loss of the protease dimerization inhibition activity of tipranavir (TPV) and its association with the acquisition of resistance to TPV by HIV-1.
Q52671185Mechanism of Darunavir (DRV)'s High Genetic Barrier to HIV-1 Resistance: A Key V32I Substitution in Protease Rarely Occurs, but Once It Occurs, It Predisposes HIV-1 To Develop DRV Resistance.
Q24337758Members of RTP and REEP gene families influence functional bitter taste receptor expression
Q34737640Novel HIV-1 protease inhibitors (PIs) containing a bicyclic P2 functional moiety, tetrahydropyrano-tetrahydrofuran, that are potent against multi-PI-resistant HIV-1 variants
Q34045363Novel protease inhibitors (PIs) containing macrocyclic components and 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane that are potent against multi-PI-resistant HIV-1 variants in vitro.
Q33806545Optimization of a weak 3' splice site counteracts the function of a bovine papillomavirus type 1 exonic splicing suppressor in vitro and in vivo
Q44058777Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization.
Q54527450Rapid and efficient gene splicing using megaprimer-based protocol.
Q33934539Structural requirements of bitter taste receptor activation
Q34719709The transmembrane domain of the molecular chaperone Cosmc directs its localization to the endoplasmic reticulum
Q33787297Utilization of the bovine papillomavirus type 1 late-stage-specific nucleotide 3605 3' splice site is modulated by a novel exonic bipartite regulator but not by an intronic purine-rich element

Search more.